Innate Pharma announces its turnover for the first quarter of 2010 and updates on its cash situation

Upcoming events

5th Annual European Life Science CEO Forum (Sachs forum)
06/03/2012 - 07/03/2012

Hervé Brailly, CEO, is invited to the panel discussion "French Public Markets – Breakthrough Technologies Panel".

Zurich,Switzerland

More info
Smallcap Event
12/04/2012 - 13/04/2012

Paris, France

More info

Innate Pharma announces its turnover for the first quarter of 2010 and updates on its cash situation

May 5, 2010

Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces a turnover of 0.1 million euros (105 thousand euros) for the first quarter of 2010, compared with 2.5 million euros (2,488 thousand euros) for the same period in 2009.

Download Area
PR in English
CP en Français